Dr Ravi Kumar Dandamudi, Consultant Clinical Oncologist

Dr Ravi Kumar Dandamudi

Consultant Clinical Oncologist

Book online
|

Dr Ravi Kumar Dandamudi Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR

Consultant Clinical Oncologist

Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR

Dr Ravi Kumar Dandamudi

Consultant Clinical Oncologist Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR

Book online
|
Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR
HCA-Healthcare-UK

Areas of expertise

  • Prostate
  • Bladder
  • Ureter
  • Radiotherapy
  • Breast cancers
HCA-Healthcare-UK

Address

About Dr Ravi Kumar Dandamudi

GMC number: 5196853

Year qualified: 1996

Place of primary qualification: University of Health Sciences

Dr Ravi K Dandamudi is a Consultant Clinical Oncologist based in Wolverhampton, providing both NHS and private oncology care. He has been serving as a Consultant Oncologist at the Royal Wolverhampton Hospitals NHS Trust since 2015. In private practice, he consults at GenesisCare Birmingham and Nuffield Health Wolverhampton Hospital.

He graduated in 1996 and completed his higher specialist oncology training in the West Midlands. He specialises in the treatment of bladder, prostate, breast, and gynaecological cancers, offering a full range of modern treatment options tailored to each patient.

Dr Dandamudi is highly experienced in delivering advanced radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and adaptive radiotherapy, particularly for prostate cancer. He is also skilled in gynaecological brachytherapy.

In addition to radiotherapy, he offers chemotherapy and immunotherapy for bladder cancer. He maintains a strong interest in clinical research, particularly in the development of new treatment strategies for bladder cancer. His approach combines evidence-based care with the latest innovations in cancer therapy.

Areas of expertise

  • Bladder cancer
  • Brachytherapy
  • Brain metastasis
  • Breast cancer
  • Cancer prevention and screening
  • Chemotherapy
  • Clinical trials
  • Gynaecological cancers
  • Hormone therapy
  • Image guided radiotherapy (IGRT)
  • Immunotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Neoadjuvant
  • Ovarian cancer
  • Prostate cancer
  • Radiotherapy
  • Renal (kidney) cancer
  • Stereotactic ablative radiotherapy (SABR)
  • Targeted therapy
  • Urological cancers

Professional memberships

General Medical Council